Antigenicity and immunogenicity of Melan‐A/MART‐1 derived peptides as targets for tumor reactive CTL in human melanoma
- 1 October 2002
- journal article
- review article
- Published by Wiley in Immunological Reviews
- Vol. 188 (1), 81-96
- https://doi.org/10.1034/j.1600-065x.2002.18808.x
Abstract
Summary: Some cancer patients mount spontaneous T‐ and B‐cell responses against their tumor cells. Autologous tumor reactive CD8 cytolytic T lymphocyte (CTL) and CD4 T‐cell clones as well as antibodies from these patients have been used for the identification of genes encoding the target antigens. This knowledge opened the way for new approaches to the immunotherapy of cancer. In this review, we describe the characterization of the structure‐function properties of the melanocyte/melanoma tumor antigen Melan‐A/MART‐1, the assessment of the T‐cell repertoire available against this antigen in healthy individuals, and the analysis of naturally acquired and/or vaccine‐induced CTL responses to this antigen in patients with metastatic melanoma.Keywords
This publication has 72 references indexed in Scilit:
- Estimating the Precursor Frequency of Naive Antigen-specific CD8 T CellsThe Journal of Experimental Medicine, 2002
- In vivo activation of melanoma-specific CD8+ T cells by endogenous tumor antigen and peptide vaccines. A comparison to virus-specific T cellsEuropean Journal of Immunology, 2002
- Thymic Selection Generates a Large T Cell Pool Recognizing a Self-Peptide in HumansThe Journal of Experimental Medicine, 2002
- Subcellular Localization of the Melanoma-associated Protein Melan-AMART-1 Influences the Processing of Its HLA-A2-restricted EpitopeJournal of Biological Chemistry, 2001
- Primary melanoma tumour regression associated with an immune response to the tumour‐associated antigen melan‐A/MART‐1International Journal of Cancer, 2001
- Two subsets of memory T lymphocytes with distinct homing potentials and effector functionsNature, 1999
- Overlapping peptides of melanocyte differentiation antigen melan-A/MART-1 recognized by autologous cytolytic T lymphocytes in association with HLA-B45.1 and HLA-A2.1International Journal of Cancer, 1998
- HLA-A2.1–restricted Education and Cytolytic Activity of CD8+ T Lymphocytes from β2 Microglobulin (β2m) HLA-A2.1 Monochain Transgenic H-2Db β2m Double Knockout MiceThe Journal of Experimental Medicine, 1997
- Identification of epitope mimics recognized by CTL reactive to the melanoma/melanocyte-derived peptide MART-1(27-35).The Journal of Experimental Medicine, 1996
- T-cell repertoire diversity and clonal expansions in normal and clinical samplesImmunology Today, 1995